U.S. firm Cambridge Isotope Laboratories in collaboration with Hyderabad-based Chemtatva Chiral Solutions has decided to establish advanced manufacturing capabilities in Telangana.
Their joint venture plans to invest around ₹300 crore over the next three years in Genome Valley Phase 4, creating over 250 direct, high-skilled jobs and strengthen India’s position in manufacturing isotopically labelled molecules used in pharmaceutical research, diagnostics, advanced electronics, OLED materials, and semiconductor applications.
1 day ago
4






English (US) ·